|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/575 | |
| A61P 21/00 | |||
| A61P 19/02 | |||
| A61P 11/06 |
| (11) | Number of the document | 2444092 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11191434.7 |
| Date of filing the European patent application | 2009-05-28 | |
| (97) | Date of publication of the European application | 2012-04-25 |
| (45) | Date of publication and mention of the grant of the patent | 2015-09-02 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 56715 P | 2008-05-28 | US |
| (72) |
Mccall, John, M, US
Hoffman, Eric, US
Kanneboyina, Nagaraju, US
|
| (73) |
ReveraGen BioPharma, Inc.,
3910 Warner Street, Kensington, MD 20595,
US
|
| (54) | Non-hormonal steroid modulators of nf-kb for treatment of disease |
| Non-hormonal steroid modulators of nf-kb for treatment of disease |